Adult stem cell assay market seen reaching $24.75 billion by 2030

The adult stem cell assay market is forecast to grow from $11.93 billion in 2025 to $24.75 billion by 2030, driven by regenerative medicine, cell-based drug discovery and lab automation. North America led in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - The adult stem cell assay market sits at the center of regenerative medicine research, where test quality affects how quickly therapies can move from the lab into clinical use. - The market is also tied to precision medicine, cell-based drug discovery and assay validation, which are becoming more important as research volumes rise.

What happened: - The Business Research Company said the adult stem cell assay market is projected to grow from $11.93 billion in 2025 to $13.84 billion in 2026. - The market is forecast to reach $24.75 billion by 2030, representing a 15.6% CAGR over the forecast period. - The report is titled The Adult Stem Cell Assay Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The company published the report from London on Oct. 30, 2026. - The report defines adult stem cell assays as laboratory tests that analyze the behavior and characteristics of adult stem cells. - Adult stem cells can self-renew and differentiate into tissue-specific cell types. - A free sample of the report is available here. - The full report is available here.

The details: - Market growth has been supported by stem cell research programs, more funding for regenerative medicine, increased academic and clinical research, better laboratory instruments and stronger academia-industry collaboration. - The forecast period points to more clinical translation of stem cell therapies, higher demand for precision medicine research tools, more cell-based drug discovery, more automation in laboratories and tighter regulatory scrutiny of assay validation. - Emerging trends include high-throughput assay platforms, multiparametric stem cell analysis, demand for regenerative medicine testing, automated cell sorting and more standardization and reproducibility. - Adult stem cell assays measure differentiation, proliferation, migration and cell interactions. - Those measurements help assess tissue regeneration potential and therapeutic effectiveness. - Regenerative medicine demand is rising as biomedical strategies aim to replace, repair or restore cells, tissues or organs damaged by age, disease, trauma or congenital conditions. - Aging populations are increasing the need for treatments for conditions such as arthritis and cardiovascular disorders. - In July 2023, a report from the American Society of Gene & Cell Therapy and Citeline showed gene therapies in Phase II clinical trials rose 5% from 247 in Q1 2023 to 260 by the end of Q2. - North America was the largest regional market in 2025. - Asia-Pacific is expected to grow the fastest during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics and updated trend analysis.

Between the lines: - The forecast reflects a broader shift from basic stem cell research toward more standardized, automated and clinically relevant testing. - The emphasis on validation and reproducibility suggests buyers and regulators are pushing the market toward more dependable assay outputs. - Asia-Pacific’s expected growth points to rising research activity and infrastructure investment outside the traditional U.S. and European centers.

What's next: - The market’s next phase will likely depend on how quickly stem cell therapies reach routine clinical use. - Demand should also rise if automated platforms and high-throughput testing become the default in research and development workflows. - Regulatory expectations around assay validation will remain a key factor shaping product development and adoption. - The Business Research Company is promoting the report through its sales contacts and social channels, including LinkedIn, Facebook and X.